Isoquinoline poly (ADP-ribose) polymerase inhibitors to treat skin diseases associated with cellular senescence
US5589483A · kind A · utility
25Cited by
4References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 21, 1994 |
| Grant date | Dec 31, 1996 |
| Priority date | — |
| Expiry date | Dec 21, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/473
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inhibition of the enzyme poly (ADP-ribose) polymerase can delay the onset of senescence and inhibitors of the enzyme can be used to treat diseases caused or exacerbated by cellular senescence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.